» Articles » PMID: 12553912

Structural Basis for Phosphodependent Substrate Selection and Orientation by the SCFCdc4 Ubiquitin Ligase

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2003 Jan 30
PMID 12553912
Citations 244
Authors
Affiliations
Soon will be listed here.
Abstract

Cell cycle progression depends on precise elimination of cyclins and cyclin-dependent kinase (CDK) inhibitors by the ubiquitin system. Elimination of the CDK inhibitor Sic1 by the SCFCdc4 ubiquitin ligase at the onset of S phase requires phosphorylation of Sic1 on at least six of its nine Cdc4-phosphodegron (CPD) sites. A 2.7 A X-ray crystal structure of a Skp1-Cdc4 complex bound to a high-affinity CPD phosphopeptide from human cyclin E reveals a core CPD motif, Leu-Leu-pThr-Pro, bound to an eight-bladed WD40 propeller domain in Cdc4. The low affinity of each CPD motif in Sic1 reflects structural discordance with one or more elements of the Cdc4 binding site. Reengineering of Cdc4 to reduce selection against Sic1 sequences allows ubiquitination of lower phosphorylated forms of Sic1. These features account for the observed phosphorylation threshold in Sic1 recognition and suggest an equilibrium binding mode between a single receptor site in Cdc4 and multiple low-affinity CPD sites in Sic1.

Citing Articles

Structure of yeast RAVE bound to a partial V complex.

Wang H, Tarsio M, Kane P, Rubinstein J Proc Natl Acad Sci U S A. 2024; 121(50):e2414511121.

PMID: 39625975 PMC: 11648922. DOI: 10.1073/pnas.2414511121.


Initial Characterization of WDR5B Reveals a Role in the Proliferation of Retinal Pigment Epithelial Cells.

Bailey J, Ma D, Clegg D Cells. 2024; 13(14.

PMID: 39056772 PMC: 11275010. DOI: 10.3390/cells13141189.


Molecular insights and clinical implications for the tumor suppressor role of SCF E3 ubiquitin ligase.

Qi Y, Rezaeian A, Wang J, Huang D, Chen H, Inuzuka H Biochim Biophys Acta Rev Cancer. 2024; 1879(5):189140.

PMID: 38909632 PMC: 11390337. DOI: 10.1016/j.bbcan.2024.189140.


F-box proteins and gastric cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.

Yang Y, Xie Q, Hu C, Xu J, Chen L, Li Y Int J Med Sci. 2024; 21(8):1575-1588.

PMID: 38903918 PMC: 11186432. DOI: 10.7150/ijms.91584.


Protein neddylation and its role in health and diseases.

Zhang S, Yu Q, Li Z, Zhao Y, Sun Y Signal Transduct Target Ther. 2024; 9(1):85.

PMID: 38575611 PMC: 10995212. DOI: 10.1038/s41392-024-01800-9.